Chee Conley 4
4 · Syros Pharmaceuticals, Inc. · Filed Sep 12, 2024
Insider Transaction Report
Form 4
Chee Conley
Chief Commercial Officer
Transactions
- Purchase
Common Stock
2024-09-10$1.51/sh+50,000$75,260→ 72,504 total - Purchase
Common Stock
2024-09-11$1.71/sh+50,000$85,420→ 122,504 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.45 to $1.52, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.57 to $1.75, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.